SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-190362"
 

Sökning: id:"swepub:oai:DiVA.org:liu-190362" > Narrowband-UVB trea...

Narrowband-UVB treatment reduces levels of mediators of the Th17 pathway and chemotaxis in psoriatic skin without any concurring effect on mediator levels in serum

Duvetorp, Albert (författare)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten,Skanes Univ Sjukhus, Sweden
Pettersson, Kjellina (författare)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten
Soderman, Jan (författare)
Lanssjukhuset Ryhov, Sweden
visa fler...
Assarsson, Malin (författare)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten,Lanssjukhuset Ryhov, Sweden
Seifert, Oliver (författare)
Linköpings universitet,Avdelningen för cellbiologi,Medicinska fakulteten,Lanssjukhuset Ryhov, Sweden
visa färre...
 (creator_code:org_t)
JOHN LIBBEY EUROTEXT LTD, 2022
2022
Engelska.
Ingår i: EJD. European journal of dermatology. - : JOHN LIBBEY EUROTEXT LTD. - 1167-1122 .- 1952-4013. ; 32:2, s. 250-259
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Narrowband-UVB (NB-UVB) is a common and effective psoriasis treatment. It exerts its effect locally and is therefore a better model for exploring dynamics of serum biomarkers reflecting psoriasis skin disease activity compared to other treatments with systemic uptake. Objectives: To perform an exploratory study to assess potential roles of multiple disease mediators as biomarkers for psoriasis disease activity, and increase understanding of NB-UVB treatment effects in psoriatic skin. Materials & Methods: Patients with plaque psoriasis were sampled (lesional, non-lesional skin, serum) before and after full NB-UVB treatment. Samples were assessed for 78 different mediators using Luminex assays. Correlation networks were analysed to explore interactions between lesional skin mediators before and after NB-UVB treatment. Results: None of the studied serum mediators were significantly affected by NB-UVB treatment after correction for multiple testing. Thirty mediators revealed a significant difference in lesional skin compared to non-lesional skin before treatment including interleukin 23 (IL-23) and C-C motif chemokine ligand 20 (CCL20), but also novel mediators such as angiopoietin-like 4 (ANGPTL4) and pentraxin 3 (PTX3). The levels of 25 mediators in skin decreased significantly, and network analysis revealed markedly reduced cluster formations and correlations after NB-UVB. Conclusion: NB-UVB treatment reduced the concentration of mediators of the Th17 inflammatory pathway and chemotaxis in psoriatic lesional skin, but also affected less studied and novel mediators. Although the treatment affected the levels of a majority of mediators in skin, no corresponding effect was observed in serum, thus challenging the possibility of a serum biomarker reflecting skin disease activity.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)

Nyckelord

psoriasis; ultraviolet therapy; Th17 cells; interleukin 23; chemokines; biomarkers

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy